Jasper Therapeutics (JSPR) Stock Chart & Stock Price History $5.87 -0.14 (-2.33%) Closing price 01/23/2025 04:00 PM EasternExtended Trading$5.93 +0.06 (+1.09%) As of 08:49 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Jasper Therapeutics Stock Price Performance 5 Day Performance+6.53%1 Month Performance-72.96%3 Month Performance-70.50%6 Month Performance-71.71%Year-To-Date Performance-72.54%1 Year Performance-45.65% Receive JSPR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Jasper Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address JSPR Stock Chart for Friday, January, 24, 2025 JSPR Chart by TradingView Jasper Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/23/2025$6.01$5.87-2.33%$6.25$5.84526,223 shs$88.05 million01/22/2025$5.70$6.01+5.44%$6.10$5.56545,657 shs$90.15 million01/21/2025$5.51$5.70+3.45%$5.84$5.52392,193 shs$85.50 million01/20/2025$5.51$5.51$5.89$5.25720,615 shs$82.65 million01/17/2025$5.34$5.51+3.18%$5.89$5.25720,615 shs$82.65 million01/16/2025$5.82$5.34-8.25%$5.82$5.34734,373 shs$80.10 million01/15/2025$5.87$5.82-0.85%$6.03$5.69835,885 shs$87.31 million01/14/2025$6.69$5.87-12.26%$6.73$5.851.30 million shs$88.06 million01/13/2025$7.05$6.69-5.11%$6.99$6.301.12 million shs$100.36 million01/10/2025$6.99$7.05+0.86%$7.43$6.572.45 million shs$105.76 million Get the Latest News and Ratings for JSPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Jasper Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 01/09/2025$6.99$6.99$9.73$6.816.60 million shs$104.86 million01/08/2025$17.71$6.99-60.53%$9.73$6.816.60 million shs$104.86 million01/07/2025$20.87$17.71-15.14%$21.27$16.94684,418 shs$265.67 million01/06/2025$19.27$20.87+8.30%$21.06$19.64437,201 shs$313.07 million01/03/2025$21.09$19.27-8.63%$22.25$18.80444,938 shs$289.07 million01/02/2025$21.38$21.09-1.36%$22.52$21.00296,159 shs$316.37 million01/01/2025$21.38$21.38$21.70$19.92286,329 shs$320.72 million12/31/2024$20.95$21.38+2.05%$21.70$19.92286,329 shs$320.72 million12/30/2024$22.25$20.95-5.84%$22.12$20.90314,360 shs$314.27 million12/27/2024$22.50$22.25-1.11%$22.99$21.83176,895 shs$333.77 million12/26/2024$21.71$22.50+3.64%$22.85$21.70117,285 shs$337.52 million12/25/2024$21.71$21.71$22.63$21.44190,809 shs$325.67 million12/24/2024$22.12$21.71-1.85%$22.63$21.44190,809 shs$325.67 million12/23/2024$21.57$22.12+2.55%$22.35$20.76206,668 shs$331.82 million Related Companies MBX Biosciences Stock Price Chart Precigen Stock Price Chart Olema Pharmaceuticals Stock Price Chart Corvus Pharmaceuticals Stock Price Chart Contineum Therapeutics Stock Price Chart Chimerix Stock Price Chart LifeVantage Stock Price Chart enGene Stock Price Chart Taysha Gene Therapies Stock Price Chart biote Stock Price Chart Receive JSPR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Jasper Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:JSPR) was last updated on 1/24/2025 by MarketBeat.com Staff From Our PartnersVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredJUST RELEASED: HUGE NEW A.I. TRADEI’ve traded every major tech boom since the dawn of the personal computer. And I can tell you one thing wit...The Oxford Club | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jasper Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jasper Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
